Transgender CEO Martine Rothblatt of United Therapeutics speaks about House Bill 2 and the transgender controversy surrounding North Carolina's House Bill 2. Jill Knight jhknight@newsobserver.com
Transgender CEO Martine Rothblatt of United Therapeutics speaks about House Bill 2 and the transgender controversy surrounding North Carolina's House Bill 2. Jill Knight jhknight@newsobserver.com

Business

For transgender CEO, fight to repeal NC’s HB2 is personal

May 13, 2016 4:48 PM

  Comments  

Videos